Asgard Therapeutics

Asgard Therapeutics is a privately held, preclinical-stage biotechnology company dedicated to direct in vivo cell reprogramming for cancer immunotherapy. As a spin-off from Lund, the company is built on breakthrough and proprietary reprogramming technology, developing gene therapy products aimed at initiating highly efficient and personalized immune responses.